Skip to content
Triangle logo TriangleGet started
← Full study record

NCT01459653 · OUTCOME

Concomitant Antibiotic Prophylaxis

Multi-level Evaluation of Chemotherapy-induced Febrile Neutropenia Prophylaxis, Outcomes, and Determinants With Granulocyte-colony Stimulating Factor · Source last updated 2016-01-11

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
NUMBER
Unit
participants
Interval / dispersion
Not reported
Time frame
All cycles. Patients were evaluated at the enrollment cycle and then re-evaluated at each cycle for a maximum total of 6 cycles; however, the scheduling of these evaluations was left to the discretion of the physician, mean duration of study for 105 days

What was measured

Objective 2: To describe EP2006 primary or secondary prophylaxis patterns for FN over up to 6 cycles of chemotherapy, with or without prior, concurrent, or later radiotherapy or surgery.

Groups in this outcome

EP2006

Cancer patients treated with chemotherapy and who are prescribed commercially available filgrastim biosimilar for primary or secondary prophylaxis for FN.

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
EP20061447

Reported measurements

Concomitant antibiotic prophylaxis
Values in participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
EP2006175Not reportedNot reportedNot reportedNot reported
No Concomitant antibiotic prophylaxis
Values in participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
EP20061261Not reportedNot reportedNot reportedNot reported
Missing
Values in participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
EP200611Not reportedNot reportedNot reportedNot reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        value
        175
    title
    Concomitant antibiotic prophylaxis
  2. categories
    1. measurements
      1. group Id
        OG000
        value
        1261
    title
    No Concomitant antibiotic prophylaxis
  3. categories
    1. measurements
      1. group Id
        OG000
        value
        11
    title
    Missing
denoms
  1. counts
    1. group Id
      OG000
      value
      1447
    units
    Participants
description
Objective 2: To describe EP2006 primary or secondary prophylaxis patterns for FN over up to 6 cycles of chemotherapy, with or without prior, concurrent, or later radiotherapy or surgery.
groups
  1. description
    Cancer patients treated with chemotherapy and who are prescribed commercially available filgrastim biosimilar for primary or secondary prophylaxis for FN.
    id
    OG000
    title
    EP2006
param Type
NUMBER
reporting Status
POSTED
time Frame
All cycles. Patients were evaluated at the enrollment cycle and then re-evaluated at each cycle for a maximum total of 6 cycles; however, the scheduling of these evaluations was left to the discretion of the physician, mean duration of study for 105 days
title
Concomitant Antibiotic Prophylaxis
type
PRIMARY
unit Of Measure
participants

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice